CRBP - CIK 0001595097
Corbus Pharmaceuticals Holdings, Inc. trades as CRBP. This page tracks Corbus Pharmaceuticals Holdings, Inc. through 781 SEC filings, with financial statements and metrics updated as new reports are filed.
Net profit margin compressed from -1046.3% to -5176.4% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Major company event | 8-K | 2026-05-26 |
| Insider trade | 4 | 2026-05-22 |
| New insider ownership | 3 | 2026-05-22 |
| Insider trade | 4 | 2026-05-21 |
| Insider trade | 4 | 2026-05-21 |
| Insider trade | 4 | 2026-05-21 |
| Insider trade | 4 | 2026-05-21 |
| Insider trade | 4 | 2026-05-21 |
The largest companies sharing Corbus Pharmaceuticals Holdings, Inc.'s SEC industry classification (pharmaceutical preparations).
In its latest fiscal year Corbus Pharmaceuticals Holdings, Inc. reported a net loss of $78.54M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.